Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Resistance Oncology ApS
APS
Active
Advertising protection
CVR 36945125
Amaliegade 13, 1256
København K
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2015 · 10 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Resistance Oncology ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Gross profit
-9
-10
-12
-21
-16
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-9
-10
-12
-21
-16
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-9
-10
-12
-21
-16
Net financials
-0
-1
-1
-7
-19
Profit before tax
-10
-11
-13
-28
-34
Tax
-2
-2
-3
-6
-5
Net profit
-8
-9
-10
-22
-29
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
6
6
7
49
448
Equity
-23
-31
-41
-63
307
Long-term debt
0
0
0
0
0
Short-term debt
29
37
48
113
140
Total debt
29
37
48
113
140
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-1571200.0%
This company
2020
2024
Equity ratio
68.7%
This company
38.2%
Market median
+80% vs market
2020
2024
Return on equity
-9.4%
This company
18.4%
Market median
-151% vs market
2020
2024
Net profit margin (of gross profit)
-2904800.0%
This company
2020
2024
Asset turnover (of gross profit)
-0.04×
This company
2020
2024
Debt / equity
0.46×
This company
0.62×
Market median
+26% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on Resistance Oncology ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
